Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Atherosclerosis
|
August 8, 2025
Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab
Mark Atallah, Tarek Harb, Nadim Nasrallah, et al.
Journal of Cardiovascular Pharmacology
|
September 13, 2024
Peroxisome Proliferator-Activated Receptor Gamma Regulates Interleukin-6-Induced Lipoprotein (a) Gene Expression in Human HepG2 Cells
Tarek Harb, Efthymios Ziogos, Núria Amat-Alarcon, et al.
Frontiers in Medicine
|
June 30, 2022
Plasma Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in the Acute Respiratory Distress Syndrome
Thomas S Metkus, Bo Soo Kim, Steven R Jones, et al.
The American Journal of Cardiology
|
October 24, 2023
Early Initiation of PCSK9 Inhibitor Therapy Versus Placebo in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Gustavo B Justino, Leonardo B Justino, Margrit Elis Müller, et al.
Circulation. Cardiovascular Imaging
|
September 29, 2023
Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterol
Tarek Harb, Efthymios Ziogos, Michael Schär, et al.
Plos One
|
July 30, 2013
Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury
Thorsten M Leucker, Zhi-Dong Ge, Jesse Procknow, et al.
Journal of Cardiovascular Computed Tomography
|
February 7, 2024
Recent advances in cardiovascular risk assessment: The added value of non-invasive anatomic imaging
Pooja V Selvam, Gowtham R Grandhi, Thorsten M Leucker, et al.
Scientific Reports
|
February 10, 2025
Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation
David Polhemus, Diego Almodiel, Tarek Harb, et al.
Journal of the American Heart Association
|
July 18, 2020
Evolocumab, a PCSK9-Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
Thorsten M Leucker, Gary Gerstenblith, Michael Schär, et al.
American Journal of Preventive Cardiology
|
June 3, 2024
Expanded genetic testing in familial hypercholesterolemia-A single center's experience
Emily E Brown, Kathleen Byrne, Erin D Michos, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Atherosclerosis
|
August 8, 2025
Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab
Mark Atallah, Tarek Harb, Nadim Nasrallah, et al.
Journal of Cardiovascular Pharmacology
|
September 13, 2024
Peroxisome Proliferator-Activated Receptor Gamma Regulates Interleukin-6-Induced Lipoprotein (a) Gene Expression in Human HepG2 Cells
Tarek Harb, Efthymios Ziogos, Núria Amat-Alarcon, et al.
Frontiers in Medicine
|
June 30, 2022
Plasma Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in the Acute Respiratory Distress Syndrome
Thomas S Metkus, Bo Soo Kim, Steven R Jones, et al.
The American Journal of Cardiology
|
October 24, 2023
Early Initiation of PCSK9 Inhibitor Therapy Versus Placebo in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Gustavo B Justino, Leonardo B Justino, Margrit Elis Müller, et al.
Circulation. Cardiovascular Imaging
|
September 29, 2023
Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterol
Tarek Harb, Efthymios Ziogos, Michael Schär, et al.
Plos One
|
July 30, 2013
Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury
Thorsten M Leucker, Zhi-Dong Ge, Jesse Procknow, et al.
Journal of Cardiovascular Computed Tomography
|
February 7, 2024
Recent advances in cardiovascular risk assessment: The added value of non-invasive anatomic imaging
Pooja V Selvam, Gowtham R Grandhi, Thorsten M Leucker, et al.
Scientific Reports
|
February 10, 2025
Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation
David Polhemus, Diego Almodiel, Tarek Harb, et al.
Journal of the American Heart Association
|
July 18, 2020
Evolocumab, a PCSK9-Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
Thorsten M Leucker, Gary Gerstenblith, Michael Schär, et al.
American Journal of Preventive Cardiology
|
June 3, 2024
Expanded genetic testing in familial hypercholesterolemia-A single center's experience
Emily E Brown, Kathleen Byrne, Erin D Michos, et al.
Page
of 8